[go: up one dir, main page]

UA96745U - METHOD OF PREVENTING ANOMALY OF BIRTH ACTIVITIES IN WOMEN WITH PATHOLOGICAL PRELIMINARY PERIOD - Google Patents

METHOD OF PREVENTING ANOMALY OF BIRTH ACTIVITIES IN WOMEN WITH PATHOLOGICAL PRELIMINARY PERIOD

Info

Publication number
UA96745U
UA96745U UAU201410483U UAU201410483U UA96745U UA 96745 U UA96745 U UA 96745U UA U201410483 U UAU201410483 U UA U201410483U UA U201410483 U UAU201410483 U UA U201410483U UA 96745 U UA96745 U UA 96745U
Authority
UA
Ukraine
Prior art keywords
women
anomaly
birth
activities
preventing
Prior art date
Application number
UAU201410483U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Nila Oleksandrivna Zakharenko
Olena Petrivna Hnatko
Original Assignee
Univ Bohomolets Nat Medical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Bohomolets Nat Medical filed Critical Univ Bohomolets Nat Medical
Priority to UAU201410483U priority Critical patent/UA96745U/en
Publication of UA96745U publication Critical patent/UA96745U/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Спосіб профілактики аномалій пологової діяльності у жінок з патологічним прелімінарним періодом, що передбачає застосування медикаментозної терапії, причому в залежності від особливостей стану шийки матки та характеру скоротливої функції матки додатково призначають гініпрал у дозі 50 мл в 500 мл фізіологічного розчину внутрішньовенно крапельно з частотою 15 крапель на хвилину 1 раз на добу з наступним прийомом таблеток гініпралу до 8 таблеток по 5 мг на добу протягом 2 діб або істенону по 2 мл в 200 мл фізіологічного розчину внутрішньовенно крапельно, починаючи з 8-12 крапель на хвилину, 2 рази на добу під контролем артеріального тиску протягом 2 діб.Method for the prevention of anomalies of childbirth activity in women with a pathological preliminary period, which involves the use of drug therapy, and depending on the peculiarities of the state of the cervix and the nature of contractile function of the uterus additionally appoint ginipral in a dose of 50 ml in 500 ml saline intravenously intravenously minute 1 time a day, followed by administration of ginipral tablets up to 8 tablets of 5 mg per day for 2 days or Istenone 2 ml in 200 ml saline intravenously. apelno ranging from 8-12 drops per minute, 2 times a day under the control of blood pressure for 2 days.

UAU201410483U 2014-09-25 2014-09-25 METHOD OF PREVENTING ANOMALY OF BIRTH ACTIVITIES IN WOMEN WITH PATHOLOGICAL PRELIMINARY PERIOD UA96745U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201410483U UA96745U (en) 2014-09-25 2014-09-25 METHOD OF PREVENTING ANOMALY OF BIRTH ACTIVITIES IN WOMEN WITH PATHOLOGICAL PRELIMINARY PERIOD

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201410483U UA96745U (en) 2014-09-25 2014-09-25 METHOD OF PREVENTING ANOMALY OF BIRTH ACTIVITIES IN WOMEN WITH PATHOLOGICAL PRELIMINARY PERIOD

Publications (1)

Publication Number Publication Date
UA96745U true UA96745U (en) 2015-02-10

Family

ID=52989750

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201410483U UA96745U (en) 2014-09-25 2014-09-25 METHOD OF PREVENTING ANOMALY OF BIRTH ACTIVITIES IN WOMEN WITH PATHOLOGICAL PRELIMINARY PERIOD

Country Status (1)

Country Link
UA (1) UA96745U (en)

Similar Documents

Publication Publication Date Title
MX384175B (en) METHODS FOR SELECTING A T CELL LINE AND ITS DONOR FOR ADOPTIVE CELL THERAPY.
MX2016011333A (en) Drug delivery systems and methods for treatment of bladder cancer with gemcitabine.
PH12017500392A1 (en) Medical treatments based on anamorelin
CA3010568A1 (en) Oromucosal nanofiber carriers for therapeutic treatment
MX2016014346A (en) Treatment of crohn's disease with delayed-release 6-mercaptopurine.
MX2016011881A (en) Dry-powder peptide medicament.
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
GB2554591A (en) Clinical support system and method
MX2018002298A (en) METHODS OF USE OF INTERLEUCIN 10 FOR THE TREATMENT OF DISEASES AND DISORDERS.
HK1223630A1 (en) Dosage and administration anti-egfr therapeutics
UA96745U (en) METHOD OF PREVENTING ANOMALY OF BIRTH ACTIVITIES IN WOMEN WITH PATHOLOGICAL PRELIMINARY PERIOD
TW201613651A (en) Pharmaceutical composition containing polymerized camptothecin derivative and polymerized hsp90 inhibitor derivative
RU2014106575A (en) METHOD FOR PREVENTION OF BLEEDING WITH MYOMECTOMY
EA201691562A2 (en) FILTERS FOR INFUSION KITS
UA99549U (en) Method for treating symptoms of fatigue in multiple sclerosis
UA99309U (en) Method of treatment of retrobulbar neuritis
UA94465U (en) A method of prevention of scar-sclerotic changes in the postoperative period of patients with hydronephrosis
MX372644B (en) A COMBINATION OF DOSAGE UNITS FOR USE IN THE TREATMENT OF PRETERM LABOR.
Fabiny Ask the doctor. I recently took antibiotics to treat an oral infection and as a result developed a vaginal yeast infection. Can I treat it myself, and what are the most effective options?
UA96488U (en) A method for treating disorders of hemovascular hemostasis in patients with ischemic heart disease
UA101897U (en) METHOD OF PREVENTION OF PHETOPLACENTAL DYSFUNCTION IN WOMEN WITH DESTRUCTIVE TREATMENT OF CERVICAL INTRAEPITITAL NEOPLASES IN ANAMESIS
洪涛 et al. Antifungal Activities and Attenuating In Vitro MAP4K3 Kinase Activities of Poria Polysaccharide Extracts
UA97011U (en) METHOD OF TREATMENT OF WOMEN WITH PATHOLOGICAL PRELIMINARY PERIOD
EA201692163A1 (en) MEDICINE FOR THE TREATMENT OF PATIENTS WITH TINNITUS
Lu Fluorouracil/folinic-acid/irinotecan/regorafenib